fibrosis which also regressed with radiotherapy, but their patient. had a pelvic sarcoma. Heath (1979) and Bramm et al. (\979) have reported patients with vaginal masses which were found to be retroperitoneal fibrosis of the pelvis, but histologically these had a dense fibroblast infiltration rather than predominantly lymphocytic infiltration. This patient is unusual as she had a heavy lymphocytic infiltration and no ureteric obstruction. Case report A 21-year-old unmarried woman presented in her seventh pregnancy, having suffered five spontaneous abortions and one uncomplicated fullterm pregnancy in 1977. During that pregnancy a loud systolic murmur was noted, which was only investigated when symptoms of increasing dyspnoea on exertion occurred. Complete cardiological investigation was interrupted by the described pregnancy, but the diagnosis of hypertrophic cardiomyopathy was already suspected.
Symptoms of angina, palpitations (the sensation of exaggerated cardiac pulsation) and dyspnoea, without cardiac failure or hypotension, worsened as the pregnancy advanced. The patient's jerky pulse rate rose to 110 beats/min and she became dyspnoeic at rest, without improvement by beta-adrenergic blockade. When her symptoms caused concern and placental function -as measured by serial serum oestriol estimations -was persistently below the normal range, labour was induced. The labour lasted four hours with ampicillin and gentamicin prophylaxis, resulting in normal delivery of a healthy male baby weighing 2.39 kg. The patient's symptoms then quickly settled.
Discussion
The condition hypertrophic cardiomyopathy is best demonstrated echocardiographically by characteristic asymmetrical ventricular septal hypertrophy. It has a dominant inheritance with variable symptoms of dyspnoea, angina, palpitations and syncope. Clinical signs include a rapid jerky pulse, a thrusting apex beat displaced laterally, with palpable but inaudible atrial beat Milia, increased nail growth and hypertrichosis following treatment with benoxaprofen t
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Milia do not usually occur as a result of drug therapy. A case is now reported of milia, hypertrichosis and increased nail growth occurring in association with benoxaprofen therapy.
Case report
A 61-year-old woman had longstanding osteoarthrosis affecting her feet, hips and cervical spine. She had a right total hip replacement in January 1981, from which she made a good recovery, and was' then commenced on, benoxaprofen for symptomatic relief of her osteoarthrosis. She first 'Case presented to the Section of Dermatology, 19 November 1981. Accepted 30 June 1982 0141-0768/83/060525-03/$01.00;0 and ejection systolic murmur (Beeson et al. 1979) .
The physiological hypervolaemia of pregnancy is generally beneficial to the disease. In contrast, hypovolaemia, hypotension, Valsalva manoeuvres, digitalis and trinitrin are dangerous and epidural anaesthesia is contraindicated.
Oakley et al. (1979) concluded that pregnancy , is generally well tolerated by these patients. A short labour, antibiotic prophylaxis, an assisted delivery and oxytocics for the third stage are .recommended. This patient, despite causing grave concern, confirmed these recommendations. She had also noticed accelerated finger nail growth and increased growth of downy blonde vellous hair on her cheeks and backs of her fingers. Histopathological examination (Figure 2) confirmed the presence of milia. Full blood count, routine biochemistry, porphyrin' screen and antinuclear factor were all normal. Rheumatoid factor was weakly positive, with a Rose-Waaler titre of less than 1/8.
References
Discussion
Benoxaprofen (Opren, Dista) is a non-steroidal, anti-inflammatory agent used for the relief of symptoms in osteoarthrosis and rheumatoid arthritis. Pharmacologically . it' has three important actions: (I) it regulates directional movement of monocytes in response to a stimulus; (2) it inhibits the enzyme Iipoxygenase which converts arachidonic acid to the leukotrienes; (3) it is a weak inhibitor of the enzyme cyclo-oxygenase, which converts arachidonic acid to prostaglandins.
